Balyasny Asset Management L.P.

Position in LAB — Standard Biotools Inc.

CIK 1218710 Chicago, IL

Position in LAB

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$31,598

-$80,208 QoQ

Shares Held

38,535

-55.2% QoQ

Ownership

0.010%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#85

of 143 holders

Holding Since

Sep 2021

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Balyasny Asset Management L.P. holds $729,959,673 across 38 Medical Devices names. LAB ranks #34 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PEN	Penumbra Inc	1,090,163	$344,218,967
2	MDT	Medtronic plc	986,367	$77,163,489
3	GKOS	GLAUKOS Corp	491,636	$68,711,047
4	ABT	Abbott Laboratories	740,808	$67,220,917
5	EW	Edwards Lifesciences Corp	456,202	$41,268,032
6			739,829	$18,406,945
7	BBNX	Beta Bionics, Inc.	855,682	$13,408,536
8	AXGN	Axogen, Inc.	253,498	$11,709,072

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$31,598	38,535	-55.2%	Shares	Sole	2026-08-14
2025-09-30	$111,806	86,005	0.0%	Shares	Sole	2025-11-14
2025-06-30	$103,206	86,005	0.0%	Shares	Sole	2025-08-14
2025-03-31	$92,885	86,005	-88.3%	Shares	Sole	2025-05-15
2024-12-31	$1,286,257	735,004	-25.9%	Shares	Sole	2025-02-14
2024-09-30	$1,913,988	991,704	-0.6%	Shares	Sole	2024-11-14
2024-06-30	$1,766,746	998,162	-79.4%	Shares	Sole	2024-08-14
2024-03-31	$13,130,088	4,845,051	+122.0%	Shares	Sole	2024-05-13
2023-12-31	$4,822,633	2,182,187	-19.1%	Shares	Sole	2024-02-14
2023-09-30	$7,820,459	2,696,710	+28.3%	Shares	Sole	2023-11-14
2023-06-30	$4,056,261	2,101,690	+84.8%	Shares	Sole	2023-08-14
2022-06-30	$1,819,777	1,137,361	+62.5%	Shares	Sole	2022-08-15
2021-12-31	$2,744,000	700,000	+119.4%	Shares	Sole	2022-02-14
2021-09-30	$2,102,150	318,991	—	Shares	Sole	2021-12-01
No filing history on record for this holder in this stock.